{"name":"Emcure Pharmaceuticals","slug":"emcure-pharmaceuticals","ticker":"EMCURE.NS","exchange":"NSE","domain":"emcure.com","description":"Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.","hq":"Pune, Maharashtra, India","founded":0,"employees":"","ceo":"","sector":"Specialty Pharma — HIV / Oncology / Cardiovascular","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":1675.7,"stockChange":18.7,"stockChangePercent":1.13,"marketCap":"$3.3B","metrics":{"revenue":961104878.8579123,"revenueGrowth":16.7,"grossMargin":60.3,"rdSpend":0,"netIncome":96528931.34373069,"cash":15405284.465455616,"dividendYield":18,"peRatio":34.4,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":961104882.1996,"revenuePeriod":"2026-03-31","revenueHistory":[{"period":"2026-03-31","value":961104882.1996},{"period":"2025-03-31","value":824561121.75678},{"period":"2024-03-31","value":687342549.25808},{"period":"2023-03-31","value":619368862.44824}],"grossProfit":579206162.49972,"grossProfitHistory":[{"period":"2026-03-31","value":579206162.49972},{"period":"2025-03-31","value":495968481.78956},{"period":"2024-03-31","value":414830320.7921},{"period":"2023-03-31","value":367897152.74842}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":87472016.71168,"operatingIncome":143437870.98214,"operatingIncomeHistory":[{"period":"2026-03-31","value":143437870.98214},{"period":"2025-03-31","value":113275484.69924},{"period":"2024-03-31","value":95793236.74584},{"period":"2023-03-31","value":98227447.36524001}],"netIncome":96528930.17414,"netIncomeHistory":[{"period":"2026-03-31","value":96528930.17414},{"period":"2025-03-31","value":71149960.94968},{"period":"2024-03-31","value":52024124.79642},{"period":"2023-03-31","value":55557541.80706}],"eps":48.77,"epsHistory":[{"period":"2026-03-31","value":48.77},{"period":"2025-03-31","value":36.43},{"period":"2024-03-31","value":27.566646},{"period":"2023-03-31","value":29.427009}],"cash":14270886.09292,"cashHistory":[{"period":"2026-03-31","value":14270886.09292},{"period":"2025-03-31","value":12721804.99776},{"period":"2024-03-31","value":11378133.26718},{"period":"2023-03-31","value":5886173.99284}],"totalAssets":1003809666.6229401,"totalLiabilities":484106952.51392,"totalDebt":158859759.62534,"equity":516920654.68768,"operatingCashflow":98532271.9383,"operatingCashflowHistory":[{"period":"2026-03-31","value":98532271.9383},{"period":"2025-03-31","value":88941628.2967},{"period":"2024-03-31","value":114582293.4376},{"period":"2023-03-31","value":77992170.90222}],"capex":-57193715.637380004,"capexHistory":[{"period":"2026-03-31","value":-57193715.637380004},{"period":"2025-03-31","value":-42494466.95498},{"period":"2024-03-31","value":-32073100.641680002},{"period":"2023-03-31","value":-42122390.91736}],"freeCashflow":41338556.30092,"dividendsPaid":-5937030.30222,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":40473790.18598,"ebitda":51571012.83256,"period":"2026-03-31","revenue":257905502.76122,"epsBasic":null,"netIncome":25418025.19922,"rdExpense":null,"epsDiluted":null,"grossProfit":153155081.04462,"operatingIncome":39599730.00218},{"sga":null,"ebit":36734232.81658,"ebitda":47665728.63978,"period":"2025-12-31","revenue":246812666.07972,"epsBasic":12.16,"netIncome":24074875.60734,"rdExpense":null,"epsDiluted":12.16,"grossProfit":146308276.27152,"operatingIncome":37117587.05012},{"sga":null,"ebit":39051693.22266,"ebitda":49979325.21948,"period":"2025-09-30","revenue":237032381.66228,"epsBasic":12.85,"netIncome":25424395.291360002,"rdExpense":null,"epsDiluted":12.85,"grossProfit":144140982.95556,"operatingIncome":34929199.33068},{"sga":null,"ebit":33157165.01062,"ebitda":43543130.32006,"period":"2025-06-30","revenue":219354331.69638,"epsBasic":10.92,"netIncome":21611634.076220002,"rdExpense":null,"epsDiluted":10.92,"grossProfit":135601822.22802,"operatingIncome":31791354.59916},{"sga":null,"ebit":27554512.33188,"ebitda":37666981.39026,"period":"2025-03-31","revenue":211833654.71706,"epsBasic":null,"netIncome":19732352.46718,"rdExpense":null,"epsDiluted":null,"grossProfit":100328846.77726,"operatingIncome":30606413.03338},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":8.12,"netIncome":null,"rdExpense":null,"epsDiluted":8.12,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":10.38,"netIncome":null,"rdExpense":null,"epsDiluted":10.38,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1675.7,"previousClose":1657,"fiftyTwoWeekHigh":1830,"fiftyTwoWeekLow":1040,"fiftyTwoWeekRange":"1040.0 - 1830.0","fiftyDayAverage":1575.71,"twoHundredDayAverage":1453.64,"beta":0,"enterpriseValue":3463447016.3185663,"forwardPE":22.6,"priceToBook":6.42,"priceToSales":3.45,"enterpriseToRevenue":3.6,"enterpriseToEbitda":18.54,"pegRatio":0,"ebitda":186780194.94531482,"ebitdaMargin":19.4,"freeCashflow":32506892.471133698,"operatingCashflow":98532275.78124084,"totalDebt":158859758.12158054,"debtToEquity":30.6,"currentRatio":1.43,"returnOnAssets":9.6,"returnOnEquity":19.6,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":6,"targetMeanPrice":1874.33,"targetHighPrice":1976,"targetLowPrice":1640,"dividendRate":3,"payoutRatio":0.06,"fiveYearAvgDividendYield":0,"exDividendDate":1755129600,"insiderHeldPercent":81.7,"institutionHeldPercent":5.2,"sharesOutstanding":189589547,"floatShares":41611676,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":48.72,"epsForward":74.26,"revenuePerShare":485.59,"bookValue":261.12,"officers":[{"age":74,"name":"Mr. Satish Ramanlal Mehta","title":"CEO, MD & Executive Director"},{"age":43,"name":"Mr. Samit Satish Mehta","title":"President of Operations & Whole-Time Director"},{"age":73,"name":"Dr. Mukund Keshao Gurjar","title":"Chief Scientific Officer & Whole-Time Director"},{"age":62,"name":"Mr. Sunil Rajanikant Mehta","title":"Executive Director of Projects & Whole-Time Director"},{"age":48,"name":"Ms. Namita Vikas Thapar","title":"Executive Director of India Business & Whole-Time Director"},{"age":null,"name":"Mr. Tajuddin Sabir Shaikh","title":"Chief Financial Officer"},{"age":null,"name":"Ms. Amruta Jana Yangalwar","title":"Company Secretary & Compliance Officer"},{"age":null,"name":"Mr. Naveen  Soni","title":"Director of Corporate Communications & Public Relations"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.emcure.com","phone":"91 20 3507 0033"}}